Biopharma Development & Production Week - 15-17 May 2018, Hilton Shanghai Hongqiao Hotel, China

3 Co-located Conferences | 300+ Senior Pharma Attendees | 60+ Expert Speakers

The Biopharma Development & Production Week hosts China's key biopharma leaders and international experts. Prides itself as a leading industry platform for its practical contents, quality of sessions, excellent networking platform and THE gathering place for pharma, biotech, CMOs, CROs, research institutes, investors, technology and industry stakeholders.

Click link below to Register Today!

Key Session Highlights

7th Annual Cell Line Development & Engineering Asia

* High-throughput Strategies for Delivering Stable, High-Performance Clonal Cell Lines
Dong Huifang, Director of Cell Line Development, WuXi Biologics, China

* Aiming for High Productivity and Stability in the Era of CHO Genome
Sam Zhang, Senior Principal Scientist/Group Leader, Cell Line Development, Bioprocess R&D, Pfizer Inc, USA

* Liquid Engineering: CHO Cell Culture Performance Enhancement Using Small Molecules
Prof. David James, University of Sheffield, UK

8th Annual Biomanufacturing

* Building a World-Class Highly Flexible Continuous Manufacturing Facility and Quality System in China
Dr. Frank Ye, SVP of Manufacturing & Quality, Hangzhou Just Biotherapeutics Co. Ltd, China

* Building a WHO PQ Compliant New Facility
Dr. John Zeng, Executive Vice President, Bioprocess Development & Pilot Plant Manufacturing, Shanghai Zerun Biotech Co. Ltd

* Strategic Practice in Building Quality Management Systems (QMS) in China Facilities
Dr. Dennis Yu Xia, Vice President of Manufacturing and Quality, Akesio Bio

9th Annual Biosimilars Asia

* Clinical Operations and Affairs Study, Safety, Efficacy and Risk
Dr. Xin Zhang, Head of Global Clinical Operations and Affairs, Shanghai Henlius Biotech Co. Ltd, China

* Biosimilars Development in China: Challenges in Bevacizumab Clinical Trial Design
Dr. Jacqueline Ming Liu, Vice-President, TOT Biopharma, China

* Biopharma’s Case Study: Perspective on Biosimilars Market Development in US, EU and Emerging Markets, and China Market Potential and Partnerships
Bryan Kim, Vice President of Business Development, Samsung Bioepis, Korea

Download Brochure

Don’t miss the Pre Conference Workshops:
* End to End Solution for Monoclonal Antibody Manufacturing: Batch or Continuous Process
Noel Rob, Business Development Manager, Pall Life Sciences

* Artifacts in the Analysis of Protein Pharmaceuticals
Sunny Zhou, Professor, Department of Chemistry and Chemical Biology Faculty Fellow, Barnett Institute of Chemical and Biological Analysis Northeastern University, Boston, Massachusetts

For more information, please visit the event website.